CVS HEALTH CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56 USD | -0.83% |
|
+0.47% | -29.08% |
| May. 08 | Argus Research Adjusts Price Target on CVS Health to $80 From $100 | MT |
| May. 08 | Mickey Mouse on Wall Street |  |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 369B | Sales 2025 * | 388B | Capitalization | 70.89B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.66B | Net income 2025 * | 8.92B | EV / Sales 2024 * | 0.32 x |
| Net Debt 2024 * | 48.83B | Net Debt 2025 * | 45.01B | EV / Sales 2025 * | 0.3 x |
| P/E ratio 2024 * |
9.74
x | P/E ratio 2025 * |
8.31
x | Employees | 259,500 |
| Yield 2024 * |
4.71% | Yield 2025 * |
4.67% | Free-Float | 70.67% |
More Fundamentals
* Assessed data
More news
Latest transcript on CVS Health Corporation
More recommendations
More press releases
More news
| 1 day | -1.87% | ||
| 1 week | -0.64% | ||
| Current month | -18.20% | ||
| 1 month | -19.69% | ||
| 3 months | -27.52% | ||
| 6 months | -19.15% | ||
| Current year | -29.86% |
1 week
54.69
57.55
1 month
53.7071.66
Current year
53.7083.25
1 year
53.7083.25
3 years
53.70111.25
5 years
51.72111.25
10 years
51.72113.65
| Managers | Title | Age | Since |
|---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 18-11-27 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 22-01-31 |
David Falkowski
CMP | Compliance Officer | - | 11-02-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 11-01-19 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 18-11-27 |
Mary Schapiro
BRD | Director/Board Member | 68 | 17-05-09 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.92% | 17 M€ | +6.46% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 56.47 | +1.16% | 11,767,627 |
| 24-05-10 | 55.82 | +0.25% | 9,288,418 |
| 24-05-09 | 55.68 | +1.40% | 10,300,491 |
| 24-05-08 | 54.91 | -1.49% | 13,625,329 |
| 24-05-07 | 55.74 | -0.41% | 17,488,119 |
Delayed Quote Nyse, May 14, 2024 at 12:19 pm EDT
More quotes
CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows:
- medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.;
- retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®);
- medical benefits management (25.8%);
- other (0.1%).
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
56.47
USD
Average target price
71.37
USD
Spread / Average Target
+26.39%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.86% | 70.89B | |
| +17.20% | 83.07B | |
| +3.59% | 28.32B | |
| -7.84% | 17.73B | |
| +2.07% | 17.43B | |
| +0.63% | 15.64B | |
| +7.51% | 13.46B | |
| +8.40% | 12.82B | |
| +69.18% | 12.69B | |
| +68.07% | 12.32B |
- Stock Market
- Equities
- CVS Stock